Literature DB >> 8283897

Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass.

C S Rinder1, D Gaal, L A Student, B R Smith.   

Abstract

Cardiopulmonary bypass has been shown in adults to activate platelets and leukocytes, lead to the formation of circulating platelet-leukocyte conjugates, and alter adhesive receptors on both cell types. Pediatric patients with congenital heart disease undergoing cardiopulmonary bypass, however, have not been extensively studied and may represent a group at particular clinical risk for bleeding and pulmonary dysfunction. We studied 13 patients with congenital heart disease undergoing operations necessitating bypass, 7 with cyanotic and 6 with noncyanotic congenital heart disease. We determined that (1) the surface density of platelet glycoprotein Ib was significantly lower at baseline and throughout bypass in patients with cyanotic heart disease than in noncyanotic patients; (2) platelet glycoprotein Ib in both cyanotic and noncyanotic congenital heart disease decreased significantly during bypass, with a nadir of 75% of baseline values; (3) platelets were activated to a high degree, comparable with that seen in adults; (4) mean circulating monocyte-platelet conjugates rose significantly during bypass, increasing from 36% to 66% by the end of bypass, whereas neutrophil-platelet conjugates and lymphocyte-platelet conjugates declined; and (5) both monocytes and neutrophils were activated by cardiopulmonary bypass, as assessed by increased surface expression of CD11b and, in the case of monocytes, CD11b expression continued to increase even after termination of bypass. Patients with cyanotic and noncyanotic heart disease did not differ with respect to platelet or leukocyte activation or the formation of platelet-leukocyte conjugates. We conclude that in children with congenital heart disease cardiopulmonary bypass causes loss of platelet adhesion receptors, activation of platelets, formation of platelet-leukocyte conjugates, and leukocyte activation. Cyanotic and noncyanotic patients are qualitatively similarly affected; however, cyanotic patients demonstrate a baseline deficit in the platelet adhesion receptor glycoprotein Ib. These cellular changes may contribute to both the hemostatic and inflammatory complications associated with cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8283897

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

1.  Platelet activation in the postoperative period after lung transplantation.

Authors:  David I Sternberg; Daichi Shimbo; Steven M Kawut; Joydeep Sarkar; Georg Hurlitz; Frank D'Ovidio; David J Lederer; Jessie S Wilt; Selim M Arcasoy; David J Pinsky; Jeanine M D'Armiento; Joshua R Sonett
Journal:  J Thorac Cardiovasc Surg       Date:  2008-03       Impact factor: 5.209

Review 2.  Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.

Authors:  Colleen E Gruenwald; Cedric Manlhiot; Lynn Crawford-Lean; Celeste Foreman; Leonardo R Brandão; Brian W McCrindle; Helen Holtby; Ross Richards; Helen Moriarty; Glen Van Arsdell; Anthony K Chan
Journal:  J Extra Corpor Technol       Date:  2010-03

3.  Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.

Authors:  C S Rinder; H M Rinder; B R Smith; J C Fitch; M J Smith; J B Tracey; L A Matis; S P Squinto; S A Rollins
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

4.  Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.

Authors:  L Zhao; P Bath; S Heptinstall
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

5.  Use of Confidex to control perioperative bleeding in pediatric heart surgery: prospective cohort study.

Authors:  Chiara Giorni; Zaccaria Ricci; Francesca Iodice; Cristiana Garisto; Isabella Favia; Angelo Polito; Adriano Carotti; Paola Cogo
Journal:  Pediatr Cardiol       Date:  2013-07-11       Impact factor: 1.655

Review 6.  Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies.

Authors:  Jie Pan; Angelos-Aristeidis Konstas; Brian Bateman; Girolamo A Ortolano; John Pile-Spellman
Journal:  Neuroradiology       Date:  2006-12-20       Impact factor: 2.804

Review 7.  Inflammation and Oxidative Stress in the Context of Extracorporeal Cardiac and Pulmonary Support.

Authors:  Sanaz Hatami; Joshua Hefler; Darren H Freed
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

8.  Aprotinin attenuates the elevation of pulmonary vascular resistance after cardiopulmonary bypass.

Authors:  Tae-Jin Yun; Joon-Ryang Rho
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

9.  Abnormal whole blood thrombi in humans with inherited platelet receptor defects.

Authors:  Francis J Castellino; Zhong Liang; Patrick K Davis; Rashna D Balsara; Harsha Musunuru; Deborah L Donahue; Denise L Smith; Mayra J Sandoval-Cooper; Victoria A Ploplis; Mark Walsh
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.